1.Effect of Farnesyltransferase Inhibitor R115777 on Mitochondria of Plasmodium falciparum.
Young Ran HA ; Bae Geun HWANG ; Yeonchul HONG ; Hye Won YANG ; Sang Joon LEE
The Korean Journal of Parasitology 2015;53(4):421-430
The parasite Plasmodium falciparum causes severe malaria and is the most dangerous to humans. However, it exhibits resistance to their drugs. Farnesyltransferase has been identified in pathogenic protozoa of the genera Plasmodium and the target of farnesyltransferase includes Ras family. Therefore, the inhibition of farnesyltransferase has been suggested as a new strategy for the treatment of malaria. However, the exact functional mechanism of this agent is still unknown. In addition, the effect of farnesyltransferase inhibitor (FTIs) on mitochondrial level of malaria parasites is not fully understood. In this study, therefore, the effect of a FTI R115777 on the function of mitochondria of P. falciparum was investigated experimentally. As a result, FTI R115777 was found to suppress the infection rate of malaria parasites under in vitro condition. It also reduces the copy number of mtDNA-encoded cytochrome c oxidase III. In addition, the mitochondrial membrane potential (DeltaPsim) and the green fluorescence intensity of MitoTracker were decreased by FTI R115777. Chloroquine and atovaquone were measured by the mtDNA copy number as mitochondrial non-specific or specific inhibitor, respectively. Chloroquine did not affect the copy number of mtDNA-encoded cytochrome c oxidase III, while atovaquone induced to change the mtDNA copy number. These results suggest that FTI R115777 has strong influence on the mitochondrial function of P. falciparum. It may have therapeutic potential for malaria by targeting the mitochondria of parasites.
Antimalarials/*pharmacology
;
Enzyme Inhibitors/*pharmacology
;
Farnesyltranstransferase/*antagonists & inhibitors/genetics/*metabolism
;
Humans
;
Malaria, Falciparum/drug therapy/*parasitology
;
Mitochondria/*drug effects/metabolism
;
Plasmodium falciparum/drug effects/*enzymology/genetics
;
Protozoan Proteins/*antagonists & inhibitors/genetics/metabolism
;
Quinolones/*pharmacology
2.Cloning and characterization of Giardia intestinalis cyclophilin.
Hak Sun YU ; Hyun Hee KONG ; Dong Il CHUNG
The Korean Journal of Parasitology 2002;40(3):131-138
The cyclophilins (Cyps) are family members of proteins that exhibit peptidylprolyl cis-trans isomerase (PPIase, EC 5.2.1.8) activity and bind the immunosuppressive agent cyclosprin A (CsA) in varying degrees. During the process of random sequencing of a cDNA library made from Giardia intestinalis WB strain, the cyclophilin gene (gicyp 1) was isolated. An open reading frame of gicyp 1 gene was 576 nucleotides, which corresponded to a translation product of 176 amino acids (Gicyp 1). The identity with other Cyps was about 58-71%. The 13 residues that constituted the CsA binding site of human cyclophilin were also detected in the amino acid sequence of Gicyp 1, including tryptophan residue essential for the drug binding. The single copy of the gicyp 1 gene was detected in the G. intestinalis chromosome by southern hybridization analysis. Recombinant Gicyp 1 protein clearly accelerated the rate of cis--
3.Dynamin like protein 1 participated in the hemoglobin uptake pathway of Plasmodium falciparum.
Hong-chang ZHOU ; Yu-hui GAO ; Xiang ZHONG ; Heng WANG
Chinese Medical Journal 2009;122(14):1686-1691
BACKGROUNDDuring the blood stage of malaria infection, parasites internalize in the host red blood cells and degrade massive amounts of hemoglobin for their development. Although the morphology of the parasite's hemoglobin uptake pathway has been clearly observed, little has been known about its molecular mechanisms.
METHODSThe recombinant proteins from Plasmodium falciparum, dynamin like protein 1 (PfDYN1) and 2 (PfDYN2) GTPase domain, were expressed in E.coli and showed GTPase activity. By using a dynamin inhibitor, dynasore, we demonstrated the involvement of PfDYN1 in the hemoglobin uptake pathway.
RESULTSThe GTPase activity of the two recombinant proteins was inhibited by dynasore in vitro. Treatment of parasite cultures with 80 micromol/L dynasore at the ring and early trophozoite stage resulted in substantial inhibition of parasite growth and in an obvious decline of hemoglobin quantum. Furthermore, reduced intracellular hemozoin accumulation and decreased uptake of the FITC-dextran were also observed, together with distinctive changes in the ultrastructure of parasites after the dynasore treatment.
CONCLUSIONSOur results show that PfDYN1 plays an important role in the hemoglobin uptake pathway of P. falciparum and suggest its possibility of being a novel target for malaria chemotherapy.
Animals ; Antimalarials ; pharmacology ; Dynamins ; antagonists & inhibitors ; GTP Phosphohydrolases ; genetics ; metabolism ; Hemoglobins ; metabolism ; Hydrazones ; pharmacology ; Malaria, Falciparum ; metabolism ; Microscopy, Electron, Transmission ; Plasmodium falciparum ; drug effects ; metabolism ; ultrastructure ; Protozoan Proteins ; genetics ; metabolism ; Recombinant Proteins ; genetics ; metabolism
4.Prevalence of Drug Resistance-Associated Gene Mutations in Plasmodium vivax in Central China.
Feng LU ; Bo WANG ; Jun CAO ; Jetsumon SATTABONGKOT ; Huayun ZHOU ; Guoding ZHU ; Kwonkee KIM ; Qi GAO ; Eun Taek HAN
The Korean Journal of Parasitology 2012;50(4):379-384
Resistance of Plasmodium spp. to anti-malarial drugs is the primary obstacle in the fight against malaria, and molecular markers for the drug resistance have been applied as an adjunct in the surveillance of the resistance. In this study, we investigated the prevalence of mutations in pvmdr1, pvcrt-o, pvdhfr, and pvdhps genes in temperate-zone P. vivax parasites from central China. A total of 26 isolates were selected, including 8 which were previously shown to have a lower susceptibility to chloroquine in vitro. For pvmdr1, pvcrt-o, and pvdhps genes, no resistance-conferring mutations were discovered. However, a highly prevalent (69.2%), single-point mutation (S117N) was found in pvdhfr gene. In addition, tandem repeat polymorphisms existed in pvdhfr and pvdhps genes, which warranted further studies in relation to the parasite resistance to antifolate drugs. The study further suggests that P. vivax populations in central China may still be relatively susceptible to chloroquine and sulfadoxine-pyrimethamine.
Antimalarials/*pharmacology
;
China
;
Chloroquine/pharmacology
;
DNA, Protozoan/chemistry/genetics
;
Drug Resistance/*genetics
;
Folic Acid Antagonists/pharmacology
;
Genotype
;
Humans
;
Malaria, Vivax/epidemiology/*parasitology
;
Plasmodium vivax/drug effects/*genetics/isolation & purification
;
Point Mutation
;
Polymorphism, Single Nucleotide/*genetics
;
Prevalence
;
Protozoan Proteins/genetics
;
Sequence Analysis, DNA
;
Tandem Repeat Sequences/*genetics